In this episode of The MedTalk Podcast, EPM editor, Reece Armstrong speaks to Professor Saad Shakir, Director of the Drug Safety Research Unit about the organisation's work to monitor the safety of Covid-19 vaccines after they were approved for use.
Oliver Schacht, CEO of precision medicine and genomics analysis company OpGen explores what we need to do to improve our fight against antimicrobial resistance (AMR).
Scott Masiella, Director of Product Management at Stirling Ultracold discusses the environmental impact of laboratories across the industry and why change is needed for life sciences to pursue better sustainable working.
Ann Yellowlees founder of Quantics Biostatistics explores the importance of accuracy and precision in bioassays and how it can help boost manufacturing efficiency.
Joe Murphy, product & process development lead at Connect 2 Cleanrooms looks at how digital modelling is helping pharmaceutical manufacturers envisage what their cleanrooms will look like as it’s being designed.
Andrew Dunbar, general manager for EMEA at global digital consultancy, Appnovation, explores the core principles of data analytics and how pharma firms can benefit from this data revolution.
Ian Bolland is joined by Joe Rowan, president and CEO of Junkosha in Europe and the U.S to discuss the company’s recent rebrand and its inaugural Technology Innovator of the Year Award.
Dr Said Ismail, director of Qatar Genome Programme discusses the key ethical questions of precision medicine and what the industry needs to do to overcome them
Deanna Mudie, principal scientist at Lonza looks at how to increase the robustness of oral drug products and accelerate their development with biorelevant dissolution media.
Peter Cusworth, account manager for industrial automation company Yokogawa explores the challenges pharmaceutical manufacturers in the UK are facing when it comes to data integrity.
